Tyra Biosciences, Inc.

TYRA chart

Tyra Biosciences, Inc. news

• Tyra Biosciences earnings up next following bladder cancer data By Investing.com

  Investing.com India · Nov 10, 10:00 AM EST

• Tyra Biosciences Q3 Loss Widens to $51.1 Million as Research Costs Rise

  Securities.io · Nov 10, 9:17 AM EST

• Tyra Biosciences Reports Q3 2026 Results, $700.5M in Cash and Clinical Progress

  TradingView · Nov 10, 8:13 AM EST

• Form 8K Tyra Biosciences Inc For: 10 November By Investing.com

  Investing.com UK · Nov 10, 8:12 AM EST

• Tyra Biosciences Q3 net loss widens on higher R&D costs

  TradingView · Nov 10, 8:10 AM EST

• TYRA: Tyra Biosciences Inc. filed SEC Form 8-K: Results of...

  Quantisnow · Nov 10, 8:06 AM EST

• Tyra Biosciences Reports $51.1 Million Third-Quarter Net Loss

  Quiver Quantitative · Nov 10, 8:06 AM EST

• Tyra Biosciences Reports Third Quarter 2026 Financial Results and Recent Highlights

  Yahoo Finance · Nov 10, 8:00 AM EST

• Tyra Biosciences to present at key healthcare i...

  Pluang · Nov 5, 4:29 PM EST

• Tyra Biosciences to Participate in Upcoming Investor Conferences

  Yahoo Finance · Nov 5, 4:05 PM EST

• Tyra will meet investors in Boston and London; its London presentation will be webcast live.

  Stock Titan · Nov 5, 4:05 PM EST

• Tyra Biosciences (TYRA) Stock Looks Rich Against Its Book Value

  Yahoo Finance · Oct 31, 5:14 PM EDT

Tyra Biosciences, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-10
• 8-K8-K2026-11-10
• 8-K8-K2026-09-15
• 8-K8-K2026-09-09
• 10-Q10-Q2026-08-04
• 8-K8-K2026-08-04
• 8-K8-K2026-06-02
• 10-Q10-Q2026-05-13
• 8-K8-K2026-05-13
• DEF 14ADEF 14A2026-04-17
• 8-K8-K2026-04-17
• 8-K8-K2026-04-02

About Tyra Biosciences, Inc.

Ticker

TYRA (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Carlsbad, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1863127

Frequently asked questions